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A T-cell subset, defined as CD4
þCD25
hi (regulatory T-cells [Treg cells]), was recently shown to suppress T-cell activation.
We demonstrate that human Treg cells isolated from healthy donors express the HIV-coreceptor CCR5 and are highly
susceptible to HIV infection and replication. Because Treg cells are present in very few numbers and are difficult to
expand in vitro, we genetically modified conventional human T-cells to generate Treg cells in vitro by ectopic
expression of FoxP3, a transcription factor associated with reprogramming T-cells into a Treg subset. Overexpression
of FoxP3 in naı ¨ve human CD4
þ T-cells recapitulated the hyporesponsiveness and suppressive function of naturally
occurring Treg cells. However, FoxP3 was less efficient in reprogramming memory T-cell subset into regulatory cells. In
addition, FoxP3-transduced T-cells also became more susceptible to HIV infection. Remarkably, a portion of HIV-
positive individuals with a low percentage of CD4
þand higher levels of activated T-cells have greatly reduced levels of
FoxP3
þCD4
þCD25
hi T-cells, suggesting disruption of the Treg cells during HIV infection. Targeting and disruption of the
T-cell regulatory system by HIV may contribute to hyperactivation of conventional T-cells, a characteristic of HIV
disease progression. Moreover, the ability to reprogram human T-cells into Treg cells in vitro will greatly aid in
decoding their mechanism of suppression, their enhanced susceptibility to HIV infection, and the unique markers
expressed by this subset.
Introduction
There is now compelling evidence that a subset of T-cells
with regulatory activity suppresses T-cell activation in both
mice and humans (Sakaguchi et al. 1995; Asano et al. 1996;
Suri-Payer et al. 1998; Takahashi et al. 1998; Thornton and
Shevach 1998; Baecher-Allan et al. 2001; Dieckmann et al.
2001; Jonuleit et al. 2001, 2002; Levings et al. 2001; Ng et al.
2001; Taams et al. 2001). Regulatory T-cells (Treg cells) have
been shown to inhibit various autoimmune and allergic
diseases (Shevach 2000; Furtado et al. 2001; Curotto de
Lafaille and Lafaille 2002; Green et al. 2002, 2003; McHugh
and Shevach 2002), mediate transplantation and self-toler-
ance (Sakaguchi et al. 1995; Hara et al. 2001; Taylor et al.
2001, 2002; Sanchez-Fueyo et al. 2002), and block the
activation and proliferation of T-cells both in vitro and in
vivo (Takahashi et al. 1998; Thornton and Shevach 1998;
Annacker et al. 2000, 2001). These ﬁndings strongly suggest
that Treg cells play a key role in immune regulation.
Human and murine Treg cells are functionally character-
ized by a decrease in both proliferation and IL-2 secretion in
response to T-cell receptor (TCR) stimulation and by their
ability to suppress activation of conventional T-cells (Asano
et al. 1996; Takahashi et al. 1998; Thornton and Shevach 1998;
Baecher-Allan et al. 2001; Dieckmann et al. 2001; Jonuleit et
al. 2001; Levings et al. 2001; Ng et al. 2001; Taams et al. 2001,
2002). Treg cells mediate their suppressive effects only when
stimulated via their TCRs (Takahashi et al. 1998; Thornton
and Shevach 1998), although their suppressive effector
function is antigen nonspeciﬁc (Thornton and Shevach
2000). Treg cells are clearly enriched within peripheral
CD4
þ T-cells that also express the a subunit of the IL-2
receptor (CD25), which is currently the best marker for
identifying these cells (Shevach 2002). However, CD25 is also
expressed on activated effector T-cells, and not all CD4
þTreg
cells express CD25 (Annacker et al. 2001; Stephens et al.
2001). In adults, Treg cells are exclusively found in the
CD45RO
þ memory subset, and a sizable portion of these cells
express the activation marker HLA-DR and the recently
identiﬁed molecule glucocorticoid-induced tumor necrosis
factor receptor (GITR, also known as TNFRSF18) (Gumperz
et al. 2002; Lee et al. 2002). Upon activation, Treg cells
express the inhibitory receptor CTLA-4 at a higher level and
for a longer period of time than conventional T-cells (Read et
al. 2000; Salomon et al. 2000; Takahashi et al. 2000).
Interestingly, Treg cells have also been shown to express
high levels of certain chemokine receptors such as CCR4 and
CCR8 (Iellem et al. 2001).
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PLoS BIOLOGYThe forkhead transcription factor FOXP3 was recently
shown to be speciﬁcally expressed in mouse Treg cells and is
required for their development (O’Garra and Vieira 2003;
Ramsdell 2003). A mutation in the FOXP3 gene carried by the
scurfy mouse strain or a knockout of this gene causes a CD4
þ
T-cell-mediated lymphoproliferative disease characterized by
cachexia and multiorgan lymphocytic inﬁltrates (Lyon et al.
1990; Brunkow et al. 2001). The human genetic disease
immune dysregulation, polyendocrinopathy, enteropathy, X-
linked syndrome (also called X-linked autoimmunity-allergic
disregulation syndrome) is caused by mutations in the human
homolog of FoxP3 and is characterized by hyperactivation of
T-cells with autoimmune endocrinopathy, early-onset type 1
diabetes and thyroiditis, and in some cases manifestations of
severe atopy (Chatila et al. 2000; Bennett and Ochs 2001;
Bennett et al. 2001; Wildin et al. 2001; Gambineri et al. 2003).
In addition, expression of FOXP3 in conventional T-cells
either in transgenic mice or by retroviral transduction is
sufﬁcient to confer a Treg cell phenotype (Fontenot et al.
2003; Hori et al. 2003; Khattri et al. 2003). However, the role
of FoxP3 in the development of human Treg cells has not
been examined.
The role of Treg cells in controlling T-cell activation
during immune responses to pathogens such as chronic viral
infections is currently a subject of great interest. Recently it
was shown that Treg cells can regulate virus-speciﬁc or
memory CD8
þ T-cell responses, thus diminishing the magni-
tude of the immune response (Kursar et al. 2002, 2004;
Murakami et al. 2002; Suvas et al. 2003; Aandahl et al. 2004).
Because Treg cells express CD4, they are also potential
targets of HIV in vivo. HIV entry into target cells also
requires cellular expression of the chemokine receptors
CCR5 or CXCR4 in conjunction with CD4 (Boshoff et al.
1997). However, the ability of HIV to establish a persistent
infection is also critically dependent on activation signals that
regulate HIV replication within target T-cells. Quiescent T-
cells are resistant to infection unless TCR or cytokine
activation signals are provided (Unutmaz 2001). Indeed,
chronic states of T-cell hyperactivation, viral persistence,
and T-cell depletion are all hallmarks of HIV infection
(Grossman et al. 2002). Consequently, this state of chronic
immune activation combined with the direct destruction of
CD4
þ T-cells by HIV leads to a profound immunodeﬁciency
characterized by progressive deterioration of immune func-
tion (Fauci 1993). If Treg cells are lost because of HIV
infection, this could potentially result in hyperactivation of
conventional T-cells due to lack of immunoregulation. In
contrast, if Treg cells are activated to expand during certain
stages of the infection, this could have a suppressive effect on
protective immune responses against the virus. Thus, in both
scenarios dysregulation of Treg subset during HIV infection
could have a profound impact on anti-HIV immune
responses and pathogenesis of the infection.
We tested the susceptibility of both naturally occurring and
in vitro genetically reprogrammed Treg cells to HIV
infection. We found that Treg cells isolated from healthy
donors express CCR5 and are highly susceptible to HIV
infection. Ectopic expression of FoxP3 in conventional
human T-cells genetically reprogrammed them into a Treg
phenotype and enhanced their susceptibility to HIV infec-
tion. Remarkably, we also found a profound defect of
FoxP3
þCD4
þCD25
hi T-cells in HIV-infected patients with
low CD4
þ and a high percentage of activated T-cells.
Our ﬁndings have important implications in understand-
ing the role of Treg cells and the chronic activated state of T-
cells during HIV infection. Furthermore, reprogramming of
T-cells in vitro into Treg cells establishes a novel system to
understand the mechanism of T-cell suppression and
enhanced susceptibility of this subset to HIV infection.
Results
Isolation and Characterization of Human Treg Cells
To analyze susceptibility of Treg cells to HIV infection, we
ﬁrst developed a method to isolate these cells from peripheral
blood. A sizable portion of human CD4
þ T-cells (between
10%–20%) express CD25 (Figure 1A). However, approxi-
mately 1%–2% of CD4
þ T-cells within the memory subset
(CD45RO
þ) express high levels of CD25 (CD25
hi) (Figure 1A).
Previous studies suggested that human Treg cells resided
within the CD45RO
þCD25
hi subset (Baecher-Allan et al. 2001;
Taams et al. 2001). We ﬁrst performed a phenotypic analysis
ofCD45RO
þCD25
hi(referredtoasTreg),CD45RO
þCD25
low/neg
(memory T) and CD45RO
 CD25
neg (naı ¨ve T) cells. Treg cells
expressed higher levels of GITR and HLA-DR (Figure 1B),
consistent with previous reports (Baecher-Allan et al. 2001;
McHugh et al. 2002; Shimizu et al. 2002). Treg cells also
expressed high levels of CCR5 and CCR4 compared to
memory and naı ¨ve T-cells, while expression of CXCR4 and
CCR7 was lower and CXCR3 expression was similar as
compared to memory T-cells (Figure 1B).
A low proliferative response and reduced IL-2 secretion are
characteristics of Treg cells (Asano et al. 1996; Takahashi et al.
1998; Thornton and Shevach 1998; Baecher-Allan et al. 2001;
Dieckmann et al. 2001; Jonuleit et al. 2001; Levings et al. 2001;
Ng et al. 2001; Taams et al. 2001). To analyze their capacity to
proliferate and secrete IL-2 upon TCR triggering, Treg and
memory T-cells were sorted into highly puriﬁed populations
by ﬂow cytometry. Puriﬁed cells were then labeled with
carboxy-ﬂuorescein diacetate succinimidyl ester (CFSE) to
monitor cell division in a quantitative manner and stimulated
through the TCR using plate-bound anti-CD3 and soluble
anti-CD28 antibodies. The secretion of IL-2 by TCR-
stimulated Treg cells was about 10-fold lower as compared
to memory T-cells (Figure 2). Treg cells also secreted lower
levels of IL-4, IL-5, and IFNc as compared to memory T-cells
(Figure 2). The CFSE-labeled cells were analyzed 6 d after
stimulation. Treg cells exhibited little proliferation, whereas
most of the memory T-cells had divided four to ﬁve times
(Figure 3A). In order to demonstrate that puriﬁed Treg cells
also displayed suppressive activity, both naı ¨ve and CD25
low/neg
memory CD4
þ T-cells were labeled with CFSE and stimulated
under suboptimal T-cell activation conditions in the presence
of unlabeled puriﬁed autologous Treg, naı ¨ve, or memory T-
cells. Coculture with Treg cells signiﬁcantly slowed the
proliferation of TCR-stimulated resting naı ¨ve and memory
CD4
þ T-cells as compared to the coculture with either
unlabeled naı ¨ve or memory T-cells (Figure 3B and 3C). Taken
together, these results conﬁrm that human Treg cells are part
of the CD4
þCD25
hi subset of T-cells.
Treg Cells Are Highly Susceptible to HIV Infection
The ability to obtain a pure population of functional
human Treg cells provides an excellent model to study their
role in HIV pathogenesis. To determine whether Treg cells
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HIV Infection of Treg Cellswere susceptible to HIV infection, puriﬁed Treg cells were
ﬁrst activated through the TCR and were infected with either
replication-competent HIV, which uses CCR5 as a coreceptor
(R5.HIV), or replication-defective viruses pseudotyped with
vesicular stomatitis virus glycoprotein (VSV-G.HIV) that
encode green ﬂuorescent protein (GFP) as a marker of
infection (Motsinger et al. 2002). Treg and memory T-cells
challenged with VSV-G.HIV resulted in an equivalent
infection rate, while in some experiments R5.HIV resulted
in about a 2-fold higher infection rate of the Treg cells as
compared to the memory T-cells (Figure 4A). To determine
the level of HIV replication in the Treg cells as compared to
activated memory T-cells, both subsets were infected with
R5.HIV for 2 d and washed to remove input virus. Super-
natants were collected from the infected cultures daily and
p24 levels were quantiﬁed by enzyme-linked immunosorbent
assay (ELISA). HIV replicated in Treg cells as efﬁciently as in
Figure 1. Identification and Phenotype of Treg Cells
(A) Puriﬁed CD4
þ T-cells were stained with anti-CD45RO-FITC and
anti-CD25-PE antibodies. The naı ¨ve, memory, and Treg subsets were
identiﬁed as shown in boxes.
(B) Puriﬁed CD4
þ T-cells were ﬁrst stained with a pure antibody
against the cell surface molecule shown in the ﬁgure, followed by
antimouse IgG conjugated with allophycocyanin, followed by CD25-
PE and CD45RO-FITC. Gates were set for Treg, memory, and naı ¨ve T-
cells as shown in (A). These results are representative of one out of
ﬁve donors analyzed.
DOI: 10.1371/journal.pbio.0020198.g001
Figure 2. Cytokine Secretion by Treg T-cells
Sorted Treg and memory T-cells were activated using plate-bound
anti-CD3 (3 lg/ml) and soluble anti-CD28 (1 lg/ml) antibodies.
Supernatants were collected 18–24 h postactivation and analyzed for
cytokines using the CBA assay. Results are representative of cytokine
secretion from Treg and memory T-cells from three different donors.
DOI: 10.1371/journal.pbio.0020198.g002
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HIV Infection of Treg CellsFigure 3. Proliferation and Suppressive Capacity of Treg Cells
(A) Sorted Treg and memory T-cells were labeled with CFSE and then
activated through suboptimal anti-CD3 (100 ng/ml) and anti-CD28 (1
lg/ml) antibodies. Day 6 postactivation, cells were ﬁxed and CFSE
expression was analyzed by ﬂow cytometry.
(B) Resting naı ¨ve or memory CD4
þ T-cells (1.5 3 10
5 T-cells) were
labeled with CFSE and cocultured with either unlabeled puriﬁed
Treg, naı ¨ve, or memory T-cells at 1:1 ratio in 96-well plates coated
with suboptimal anti-CD3 (100 ng/ml) and anti-CD28 (1 lg/ml)
antibodies. At day 4 postactivation, cells were ﬁxed and analyzed for
CFSE expression and cell size by ﬂow cytometry.
(C) Regions were set based on 2-fold reduction in CFSE mean
intensity of naı ¨ve or memory T-cells as gated on (B), and plotted as
number of cell divisions. Results represent three separate experi-
ments from three different donors.
DOI: 10.1371/journal.pbio.0020198.g003
Figure 4. HIV Infection of Treg Cells
(A) Sorted Treg and memory T-cells were activated using plate-bound
anti-CD3 (3 lg/ml) and soluble anti-CD28 (1 lg/ml) antibodies and
concurrently infected with R5.HIV or VSV-G.HIV at a MOI of 5
(based on prior virus titration using Hut78/CCR5 cells). The
percentage of infected cells was determined by GFP expression at 3
d postinfection by ﬂow cytometry.
(B) Supernatants from Treg and memory T-cells infected with R5.HIV
cultures were collected at different time points and HIV p24 levels
were measured by ELISA.
(C) Treg cell death was assessed by analyzing infected cells at days 3
and 7 postinfection based on forward- and side-scatter analysis and in
some experiments using propidium iodine staining analysis with ﬂow
cytometry. All of the infection results are representative of one out of
ﬁve separate experiments with reproducible results. Statistical
signiﬁcance was determined using the Student’s two-tailed t test.
* p , 0.05.
DOI: 10.1371/journal.pbio.0020198.g004
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HIV Infection of Treg Cellsmemory T-cells (Figure 4B). To assess whether the virus
produced by Treg cells was infectious, supernatants from
infected cells were added to Hut78/CCR5 cells, which are
highly susceptible to HIV infection, and the titer of infectious
virus was determined by GFP expression. Treg cells produced
levels of infectious virus similar to those of the memory T
subset (data not shown). The viability of infected cultures was
also determined at days 3 and 7 to determine if HIV infection
killed Treg cells. Indeed, infection with replication-compe-
tent HIV was highly cytotoxic to both Treg and memory T-
cells (Figure 4C). We conclude that Treg cells are highly
susceptible to HIV infection and are killed by viral
replication.
Genetic Reprogramming of Conventional Human T-cells
into Treg Cells by Ectopic Expression of FoxP3
Treg cells constitute less than 1%–2% of total human T-
cells (see Baecher-Allan et al. 2001; see Figure 1). Although we
could purify several hundred thousand Treg cells from 300 ml
of blood as described below, isolation of sufﬁcient numbers of
Treg cells is clearly an obstacle to studying their function and
susceptibility to HIV infection. Recently, a transcription
factor called FOXP3 was shown to program murine T-cells
into a Treg subset (Fontenot et al. 2003; Hori et al. 2003;
Khattri et al. 2003). Therefore we hypothesized that ectopic
expression of FoxP3 in naı ¨ve T-cells could facilitate the
generation of large numbers of human Treg cells. Accord-
ingly, we subcloned FoxP3 cDNA into a HIV-derived vector
(HDV) that encodes murine CD24 (mCD24) as a marker
(Sundrud et al. 2003). CD4
þ T-cells were puriﬁed from both
neonatal cord blood (CB) and adult blood (AB), activated
through the TCR and transduced with FoxP3-expressing
HDV (HDV.FoxP3) or control HDV as described previously
(Sundrud et al. 2003). Expression of FoxP3 mRNA in
transduced cells was conﬁrmed by real-time PCR analysis
and was found to be about 50- to 100-fold higher in FoxP3
transduced primary CD4
þ T-cells as compared to control
HDV-transduced cells (data not shown).
FoxP3-transduced and control cells were expanded for 14 d
in IL-2-containing medium. Cells were then stained for
mCD24 and also for CD25, GITR, and CCR4 markers that
are expressed at higher levels on naturally occurring Treg
cells (see Figure 1). Naı ¨ve T-cells ectopically expressing FoxP3
displayed higher levels of CD25, GITR (Figure 5A), and CCR4
(Figure 5B) as compared to control transduced T-cells.
FoxP3-transduced memory T-cells displayed much less
upregulation of these markers (data not shown). However,
while the majority of these transduced T-cells also expressed
CCR5, its expression levels on FoxP3-transduced and control
T-cells were similar (Figure 5C). To determine whether
FoxP3-transduced T-cells display functional properties such
as hyporesponsiveness to TCR triggering, similar to freshly
isolated Treg cells, transduced cells were puriﬁed by sorting
mCD24
þ cells as described previously (Sundrud et al. 2003).
Equal numbers of puriﬁed cells were then stimulated using
plate-bound anti-CD3 and soluble anti-CD28 antibodies, and
cytokine secretion was monitored. Secretion of IL-2 from
both CB and AB naı ¨ve T-cells was reduced between 8- and 10-
fold in FoxP3-expressing cells as compared to control
cultures (Figure 6A). Secretion of IL-4, IL-5, and IFNc was
also reduced in FoxP3-expressing naı ¨ve T-cells (Figure 6B). In
contrast, FoxP3-transduced memory T-cells secreted similar
levels of IL-2 as compared to cells transduced with HDV alone
(Figure 6A). To assess the proliferative capacity of FoxP3-
expressing cells, transduced cells were labeled with CFSE and
stimulated through the TCR. After 4 d of activation, very few
FoxP3-transduced naı ¨ve T-cells had divided as compared to
control lines (Figure 7A). Although, FoxP3-expressing mem-
ory T-cells also divided fewer times as compared to HDV-
Figure 5. Phenotype of FoxP3 Transduced T-cells
Puriﬁed CB naı ¨ve CD4
þ T-cells were activated through the TCR and
transduced with either HDV.FoxP3 or HDV. Cells were expanded for
14 d in IL-2-containing medium and stained with (A) anti-mCD24,
anti-GITR, and anti-CD25, (B) anti-mCD24 and anti-CCR4, or (C)
anti-mCD24 and anti-CCR5 antibodies. Gates were set on the
mCD24-positive population (transduced), and expression of surface
molecule was analyzed. The expression of these markers in the CD24-
negative portion of both cultures was identical (data not shown).
These results are representative of T-cells isolated from ﬁve different
donors and transduced independently.
DOI: 10.1371/journal.pbio.0020198.g005
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HIV Infection of Treg Cellstransduced cells, the effect of FoxP3 was greatly diminished
in this subset (Figure 7A).
The key characteristic of Treg cells is suppression of
conventional T-cells activated through the TCR (Takahashi et
al. 1998; Thornton and Shevach 1998). Thus, puriﬁed resting
CD4
þ T-cells were labeled with CFSE and cocultured with
unlabeled naı ¨ve or memory T-cells that were transduced
either with HDV.FoxP3 or HDV and then stimulated through
the TCR as described for freshly isolated Treg cells (see Figure
3). FoxP3-expressing naı ¨ve T-cells, both from CB or AB,
completely suppressed proliferation of target resting CD4
þT-
cells (Figure 7B and 7C). A signiﬁcant but lower level of
suppression was apparent with memory T-cells transduced
with FoxP3 (Figure 7C). We conclude that ectopic expression
of FoxP3 in naı ¨ve human T-cells recapitulates key phenotypic
and functional features of naturally occurring Treg cells.
T-cells Ectopically Expressing FoxP3 Are More Susceptible
to HIV Infection
We next determined the susceptibility of FoxP3-expressing
cells to HIV infection. FoxP3-transduced cells were puriﬁed
by ﬂow cytometry sorting based on mCD24 expression and
activated through their TCR or cultured in IL-2-containing
medium. Subsequently, activated cells were challenged with
either VSV-G.HIV or R5.HIV. Remarkably, FoxP3-expressing
cells were infected at a level about 2- to 3-fold higher than
control cells at different concentrations of the virus, in both
activated and nonactivated conditions (Figure 8A). FoxP3-
expressing cells stimulated at suboptimal levels of anti-CD3
antibody also displayed a very similar enhancement of
infection compared to HDV-transduced cells (data not
shown).
We next analyzed the level of HIV replication and cell
death in FoxP3-expressing cells as compared to HDV-
transduced T-cells. Activated FoxP3-expressing and control
cells were infected with R5.HIV, and culture supernatants
were collected daily from day 3 postinfection. FoxP3-
expressing cells showed increased HIV-infection and repli-
cation (Figure 8B). Infectivity of virus produced by FoxP3-
expressing cells, as assessed on Hut78/CCR5 cells, as well as
cell death in these cultures, was also proportionately higher
(data not shown). These ﬁndings demonstrate that the
expression of FoxP3 renders CD4
þ primary T-cells more
susceptible to HIV infection.
HIV-Infected Patients Have Greatly Decreased Levels of
FoxP3-Expressing CD4
þCD25
hi T-cells
Our ﬁndings that Treg cells are highly susceptible to HIV
infection prompted us to determine if this subset was
disturbed within HIV-infected individuals. However, a major
difﬁculty in such analysis is that many of the cell surface
markers that deﬁne Treg cells are also expressed on activated
T-cells (CD25, HLA-DR, GITR). Because a portion of HIV-
positive individuals contain high levels of activated T-cells,
simple cell surface analysis would not be sufﬁciently reliable
to quantify Treg cells in these donors. Therefore, we utilized
FoxP3 expression as the most reliable marker that deﬁnes
Treg cells. To accomplish this, we sorted CD4
þCD25
hi, naı ¨ve,
and memory T-cells from 11 HIV-negative, healthy donors
(median age, 31; 64% male) and 24 HIV-infected individuals
(median age, 38; 85% male; 88% receiving antiretroviral
therapy). Total RNA was then isolated from each subset and
FoxP3 mRNA expression was quantiﬁed using real-time PCR
analysis. In order to normalize for experimental variability,
FoxP3 expression of the CD4
þCD25
hi cells was normalized to
GAPDH levels from the same samples and compared to the
naı ¨ve T-cell subset isolated from the same donor. We found
that within HIV-negative subjects there was on average a 49-
fold higher level of expression of FoxP3 in CD4
þCD25
hi cells
as compared to naı ¨ve T-cells (Figure 9A). The lowest FoxP3-
expressor in the healthy subject group had 16-fold higher
FoxP3 expression as compared to naı ¨ve T-cells from the same
donor (Figure 9A). There was a similar increase in FoxP3
expression as compared to memory T-cells (data not shown).
In HIV-positive subjects FoxP3 expression was only increased
a mean of 25-fold in CD4
þCD25
hi cells. In contrast to healthy
Figure 6. Cytokine Production by FoxP3-Transduced T-cells
CD4
þ naı ¨ve T-cells isolated from CB (CB-naı ¨ve) and AB (AB-naı ¨ve)
and memory T-cells from AB (AB-memory) were transduced with
HDV or HDV.FoxP3 as described in Figure 5. Transduced T-cells
were puriﬁed through magnetic sorting of mCD24
þ cells and
activated using plate-bound anti-CD3 and soluble anti-CD28 anti-
bodies. Supernatants were collected at 18–24 h postactivation and
analyzed for (A) IL-2 production or (B) IFNc, IL-4, and IL-5
production from HDV or HDV.FoxP3-tranduced naı ¨ve T-cells, using
CBA assay. The results represent ﬁve separate experiments from
different donors with similar relative differences in cytokine
production.
DOI: 10.1371/journal.pbio.0020198.g006
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HIV Infection of Treg Cellsdonors, we also observed that in about half of the HIV-
positive subjects, CD4
þCD25
hi cells expressed very low to
undetectable levels of FoxP3 (Figure 9A). FoxP3 expression in
memory T-cells was similar in HIV-positive and HIV-negative
subjects (Figure 9A).
Progressive HIV disease is associated with decreased CD4
þ
T-cell percentages and increased levels of activated T-cells.
We hypothesized that this hyperactivation may be due to a
loss of Treg cells. Therefore, to further evaluate relationships
between FoxP3 expression and these parameters in HIV-
infected individuals, samples were divided into low FoxP3
expressors (less than 10-fold higher expression in
CD4
þCD25
hi T-cells compared to naı ¨ve T-cells, designated
FoxP3-low) versus high FoxP3 expressors (greater than 10-
fold higher expression compared to naı ¨ve T-cells, designated
FoxP3-high). HIV-positive subjects with a FoxP3-low proﬁle
had signiﬁcantly lower CD4
þT-cell percentages, while FoxP3-
high HIV-positive subjects had CD4
þ T-cell percentages
comparable to HIV-seronegative subjects (Figure 9B). Sim-
ilarly, HIV-positive FoxP3-low subjects had signiﬁcantly
greater activated CD4
þT-cells (CD4
þHLA-DR
þ) than either
HIV-positive subjects with FoxP3-high proﬁles or HIV-sero-
negative subjects (Figure 9C). Interestingly, the CD4
þCD25
hi
T-cells are also signiﬁcantly increased in FoxP3-low expres-
sors as compared to HIV-negative or HIV-positive FoxP3-
high expressors (Figure 9D). These differences are most likely
due to recently activated T-cells that also express high levels
of CD25, as shown by higher HLA-DR expression on T-cells
from the same subset of subjects (Figure 9C). Among HIV-
positive subjects there was no signiﬁcant association between
FoxP3 expression and plasma HIV-1 RNA concentration, age,
race, sex, or whether the subject was receiving antiretroviral
therapy (P . 0.05 for each comparison). These ﬁndings
demonstrate that a decrease in Treg cells is associated with
HIV disease progression and suggest that loss of Treg cells
may contribute to increased T-cell hyperactivation.
Discussion
In this study we demonstrated that human Treg cells are
highly susceptible to HIV infection and that ectopic
expression of FoxP3 genetically reprograms conventional
naı ¨ve T-cells, phenotypically and functionally, into Treg cells.
Remarkably, overexpression of FoxP3 also greatly enhances
Figure 7. Proliferation and Suppression by FoxP3-Expressing Cells
(A) Puriﬁed CD4
þ naı ¨ve and memory T-cells were transduced with
either HDV.FoxP3 or HDV as described. The transduced T-cells were
labeled with CFSE and activated with anti-CD3 (100 ng/ml) and anti-
CD28 (1 lg/ml) antibodies. Day 6 postactivation, cells were ﬁxed and
analyzed for CFSE expression by ﬂow cytometry.
(B) Resting CD4
þ T-cells (1.5 3 10
5) were labeled with CFSE and
cocultured at 1:1 with either unlabeled sorted HDV.FoxP3-expressing
or HDV-transduced CB naı ¨ve T-cells and activated with anti-CD3
(100 ng/ml) and anti-CD28 (1 lg/ml ) antibodies. At 4 d postactivation,
cells were stained with mCD24-PE as a marker for infection.
(C) Naı ¨ve and memory T-cells isolated from adult blood were
transduced with HDV.FoxP3 or HDV. A coculture suppression
experiment was set up with resting puriﬁed autologous CD4
þ T-cells
as described above. Region was set on mCD24 negative CFSE
þ cells
(target resting CD4
þT-cells) as shown in (B), and CFSE expression was
analyzed 6 d poststimulation by ﬂow cytometry. The results are
representative of three separate experiments.
DOI: 10.1371/journal.pbio.0020198.g007
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Although Treg cells constitute a small subset of the total T-
cells in humans (less than 1%–2%) and thus may not be a
signiﬁcant target population for HIV, they appear to have
very potent suppressive activity against activation of T-cells
(Takahashi et al. 1998; Thornton and Shevach 1998; Baecher-
Allan et al. 2001; Curotto de Lafaille and Lafaille 2002). Here
we demonstrate that FoxP3-expressing CD4
þCD25
hi T-cells
are greatly decreased in a portion of HIV-infected individuals
with low CD4 and high activated T-cells, suggesting a loss of
Treg cells. We therefore propose that infection and dis-
ruption of Treg cells during HIV infection could have a major
inﬂuence on T-cell homeostasis and immune regulation.
Similar to previous reports, our ﬁndings demonstrate that
human Treg cells appear to be enriched within the CD25
hi
subset of CD4
þ T-cells. However, it is not clear if Treg cells
are the only population represented in the CD25
hi subset
since they share this phenotype with recently activated T-
cells. Indeed, a portion of puriﬁed CD25
hi cells proliferated
and their suppressive function was less efﬁcient as compared
to FoxP3-expressing cells (see Figure 3). Because the
puriﬁcation of Treg cells is rather arbitrary (brightest 1%–
2% of antibody-stained CD25
þ memory T-cells), it is
conceivable that there is sizable contamination of non-Treg
cells in these sorted preparations. In addition, the differences
seen in the infection susceptibility of Tregs as compared to
FoxP3-expressing cells may also be partly due to presence of
non-Treg activated T-cells within the puriﬁed cells. Identi-
ﬁcation of the Treg subset in disease conditions with chronic
T-cell activation, such as HIV, is even more problematic
because a large proportion of CD4
þCD25
hi cells possibly
represent recently activated T-cells. Availability of large
numbers of genetically reprogrammed Treg cells should
facilitate the identiﬁcation of novel markers that can reliably
detect human Treg cells.
Our results clearly demonstrate that, similar to the mouse
system, ectopic expression of FoxP3 is sufﬁcient to recapit-
ulate all of the characteristics of Treg cells, including lower
cytokine secretion, higher expression of CD25 and GITR, and
their suppressive functions. This system has allowed us to
generate large numbers of Treg cells, which will be invaluable
in characterizing their suppressive function as well as
mechanisms of enhanced HIV susceptibility. The ability to
genetically manipulate primary T-cells to reprogram them
into the Treg phenotype also could have profound implica-
tions for preventing graft-versus-host disease, a serious
clinical condition that can be manifested following hema-
topoietic cell transplantation (Hoffmann et al. 2002; Taylor et
al. 2002).
It is interesting to note that naı ¨ve T-cells are more prone to
reprogramming into a Treg phenotype than memory T-cells
are. This loss in ﬂexibility of reprogramming with a master
transcription factor is reminiscent of Th1- and Th2-type T-
cell reprogramming with ectopic expression of lineage-
speciﬁc transcription factors T-bet and GATA-3, respectively
(Sundrud et al. 2003). The loss of ﬂexibility in genetic
modiﬁcation of effector/memory T-cells could reﬂect herit-
able epigenetic changes at effector gene loci that might
otherwise be responsive to FoxP3-mediated transcription. A
recent study supports this hypothesis by demonstrating that
lineage-committed human memory cells failed to modify
their histone acetylation patterns of cytokine genes, unlike
naı ¨ve T-cells, to differentiate into Th1- or Th2-type cells
(Messi et al. 2003).
The cause of progressive depletion of CD4
þ cells and the
reason for high T-cell activation or turnover during HIV
infection remains controversial (Hazenberg et al. 2000;
Grossman et al. 2002). It is thought that HIV-mediated
destruction of CD4
þ T-cells results in decline of this subset
and that to maintain homeostasis the immune system
attempts to replenish this subset, resulting in a massive
turnover of T-cells (Ho et al. 1995; Wei et al. 1995; Perelson et
al. 1996; Mohri et al. 1998, 2001). This excessive turnover rate
eventually compromises proper function of homeostatic
responses. Alternatively, T-cell depletion could result from
disrupted thymic and peripheral homeostatic mechanisms by
virus-induced generalized T-cell activation and gradual
Figure 8. HIV Infection of FoxP3-Expressing T-cells
(A) HDV.FoxP3 and HDV-transduced T-cells were activated using
plate-bound anti-CD3 (100 ng/ml) and soluble anti-CD28 (1 lg/ml)
antibodies or maintained in IL-2-containing medium. Cells were
concurrently infected at different MOI of VSV-G.HIV, and infection
was determined by GFP expression at 72 h postinfection by ﬂow
cytometry.
(B) Supernatants were collected at different time points from
R5.HIV-infected HDV.FoxP3-expressing or HDV-transduced cell
cultures, and HIV p24 levels were measured by ELISA. The
percentages of infected cells at days 3, 9, and 16 for HDV.FoxP3
were 2, 10, and 26, and for HDV were 0.8, 10, and 18, respectively.
DOI: 10.1371/journal.pbio.0020198.g008
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depletion (Hazenberg et al. 2000; Grossman et al. 2002).
Indeed, several mechanisms control unwanted activation of
T-cells, including thymic deletion of autoreactive T-cells and
induction of anergy in the periphery. In addition to these
passive mechanisms, recent evidence clearly demonstrates
that Treg cells exert an active suppression of T-cell activation.
We postulate that the high susceptibility of Treg cells to HIV
in vivo, as demonstrated by our in vitro studies, could result
in gradual elimination of this subset. This Treg cell decline
during HIV infection would in turn reduce active suppression
of conventional T-cells and, hence, contribute to hyper-
activation of T-cells. Our analyses of peripheral blood T-cells
from HIV-infected subjects support this hypothesis that loss
of Treg cells during HIV infection contributes to HIV disease
progression. Indeed, we found that in a subset of HIV-
infected subjects, the CD4
þCD25
hi T-cell subset had greatly
reduced FoxP3 expression, suggesting that these cells
Figure 9. FoxP3 Expression in Purified CD4
þCD25
hi (Treg), Naı ¨ve, and Memory T-cells from HIV-Infected and Healthy Individuals
(A) RNA was isolated from sorted Treg, naı ¨ve, and memory T-cells from HIV-positive (n = 24) and HIV-negative (n = 11) subjects, followed by
cDNA synthesis. FoxP3 expression was quantiﬁed by TaqMan real-time PCR. The FoxP3-fold difference expression was calculated for
CD4
þCD25
hi (Treg) versus naı ¨ve (N), and memory (Mem) versus naı ¨ve (N) T-cells. Treg cells sorted from HIV-positive subjects were further
subdivided into two groups based on FoxP3 expression of Treg compared to naı ¨ve T-cells (FoxP3-high, n = 13, FoxP3 difference .10-fold;
FoxP3-low, n = 11, FoxP3 difference ,10-fold; HIV-negative, n = 9). These groups were stained with anti-CD3, anti-CD4, anti-CD45RO, anti-
CD25, and anti-HLA-DR and analyzed by ﬂow cytometry for (B) CD4
þ T-cell percentage, (C) activated T-cell percentage (CD4
þHLA-DR
þ), and
(D) CD4
þCD25
hi percentage. Horizontal lines identify means. Statistical signiﬁcance between groups was determined by Mann–Whitney U test
and shown on top of each ﬁgure.
DOI: 10.1371/journal.pbio.0020198.g009
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The presence of a higher percent of activated T-cells in this
FoxP3-low proﬁle supports this conjecture. The HIV-infected
subjects with lower levels of FoxP3
þ T-cells also contained a
lower percentage of CD4
þ T-cells. It is conceivable that the
loss of Treg cells may be a correlative factor for disease
progression; however, more detailed prospective studies will
be required to address this important implication of our
ﬁndings.
Our ﬁndings show a 2- to 3-fold enhancement of HIV
infection in FoxP3-expressing T-cells. While freshly puriﬁed
Treg and memory T-cells are similar in their susceptibility to
HIV infection, activated effector T-cells become gradually
more resistant to infection (unpublished results). Indeed,
preactivated T-cells require reactivation to render them
susceptible to infection after about 1–2 weeks in culture
(unpublished results). We do not yet know the mechanisms by
which FoxP3 renders activated T-cells more susceptible to
infection; however, two possibilities can be considered: (1)
FoxP3 may be overcoming innate resistance factor(s) that
accumulate in activated T-cells that block HIV infection, or
(2) FoxP3 expression may be inducing critical host factors
that are required for efﬁcient completion of the HIV life
cycle in primary T-cells. It is important to note that since
FoxP3 expression enhances VSV-G.HIV single-round infec-
tions, it likely affects an early, postentry step in viral
replication. Determining the mechanisms by which FoxP3
enhances HIV infection could reveal host factors involved in
this process.
In summary, our results indicate that both naturally
occurring and genetically reprogrammed Treg cells are
susceptible to HIV infection and that ectopic FoxP3
expression greatly increases the susceptibility of T-cells to
HIV infection. Our ﬁnding that FoxP3-expressing
CD4
þCD25
þ T-cells are greatly reduced in HIV patients with
low CD4
þ T-cell percentages and increased T-cell activation
suggests that loss of Treg cells may contribute to HIV disease
progression. Further prospective studies will be required to
unravel the role of this important subset in HIV infection.
The ability to genetically reprogram conventional human T-
cells to generate Treg cells will also lead the way to identifying
unique markers expressed on this population in order to
further investigate their status in HIV-infected individuals.
Moreover, understanding how FoxP3 enhances HIV infection
and programs T-cells into the Treg subset could help in the
identiﬁcation of novel host factors that mediate HIV
infection in primary T-cells and decoding the molecular
mechanisms by which Treg cells mediate their suppressive
function.
Materials and Methods
Study subjects and statistical analysis. Healthy subjects (n = 11)
were adults who were HIV-negative and with no history of chronic
viral infections such as Hepatitis B or C. Blood samples from adults
with HIV infection (n = 24) were obtained during routine primary
care visits at the Comprehensive Care Center, Vanderbilt University
Medical School, Nashville, Tennessee, United States. There were no
selection criteria based on race or sex. All subjects provided written
consent, and the study was approved by the Vanderbilt Institutional
Review Board. Continuous variables were compared by a Mann–
Whitney U test, and categorical variables by an v
2 test. All signiﬁcance
levels were based on two-tailed tests. Statistical analyses were
performed using SPSS, version 12.0 (SPSS, Chicago, Illinois, United
States).
Cell isolation and culture. Peripheral blood mononuclear cells
(PBMCs) were separated from buffy coats of healthy and HIV-positive
donors through Ficoll–Hypaque separation (Pharmacia-LKB Tech-
nology, Uppsala, Sweden). Resting CD4
þ T-cells were puriﬁed as
previously described (Unutmaz et al. 1999). This puriﬁcation protocol
typically resulted in 99.5% purity of positively selected cells, as
determined by postpuriﬁcation ﬂuorescence-activated cell sorting
(FACS) analysis. To isolate Treg cells, PBMCs, or puriﬁed CD4
þ cells,
were stained with CD45RO, CD25, CD4, and HLA-DR antibodies (BD
Biosciences Pharmingen, San Diego, California, United States), and
CD4
þCD45RO
þCD25
hi and CD4
þCD45RO
 CD25
low/neg cells were
sorted using ﬂow cytometry (FACS Aria; BD Biosciences Pharmin-
gen). For some experiments, adult CD4
þ T-cells were sorted into
CD45RO
þ (memory) and CD45RO
  (naı ¨ve) T-cells with anti-CD45RO
conjugated magnetic beads (Miltenyi Biotec, Bergisch Gladbach,
Germany) using AutoMACS (Miltenyi Biotec). Puriﬁed resting T-cells
were activated by cross-linking with plate-bound anti-CD3 antibody
(OKT-3; American Type Culture Collection, Manassas, Virginia,
United States) and soluble anti-CD28 antibody (1 lg/ml, BD
Biosciences Pharmingen). The plates were ﬁrst coated with goat
antimouse IgG (10 lg/ml, CalTag Laboratories, Burlingame, Califor-
nia, United States) followed by either 3 lg/ml anti-CD3 for optimal
TCR stimulation or 100 ng/ml anti-CD3 for suboptimal stimulation.
The culture medium used in all experiments was RPMI (Life
Technologies, Carlsbad, California, United States) and was prepared
as previously described (Motsinger et al. 2002). All cytokines were
purchased from R & D Systems (Minneapolis, Minnesota, United
States). Monocyte-derived dendritic cells were generated as previ-
ously described (Motsinger et al. 2002). Superantigen, staphylococcal
enterotoxin B (Sigma, St. Louis, Missouri, United States) was used to
stimulate resting T-cells in the presence of dendritic cells (Motsinger
et al. 2002).
Virus production and infections. VSV-G.HIV particles were
generated as previously described (Unutmaz et al. 1999). R5-HIV
was prepared similarly by transfecting 293T-cells with HIV that
encodes R5-tropic (BAL) envelope and enhanced GFP (Clontech, Palo
Alto, California, United States) in place of the nef gene as previously
described (Unutmaz et al. 1999). Typically viral titers ranged from 1–5
3 10
6 ifu/ml for replication-competent viruses and 10–30 3 10
6 for
VSV-G.HIV. T-cells were infected at varying multiplicities of
infection (MOI), and infection was quantiﬁed by GFP expression
using ﬂow cytometry. In some experiments, cells inoculated with virus
were centrifuged for 1 h at 2,000 rpm to enhance infectivity, as
described by O’Doherty et al. (2000). Viral replication in T-cell
cultures was determined by measuring p24 levels within supernatants
by an ELISA (Motsinger et al. 2003), and infectious virus production
by infected T-cells was determined by culturing Hut78 cells
expressing CCR5 (Hut78/CCR5) (Wu et al. 2002) in infected T-cell
supernatants.
CFSE labeling. Cell division was measured by labeling the T-cells
with CFSE (Molecular Probes, Eugene, Oregon, United States).
Puriﬁed cells were ﬁrst washed and resuspended in PBS. While
vortexing the cells, CFSE was added at a ﬁnal concentration of 5 lM.
The mixture was vortexed for an additional 15 s and incubated at
378C for 3 min. Labeling was quenched by addition of 50% fetal calf
serum in PBS. Cells were washed one more time with 50% serum PBS,
followed by two washes with RPMI-supplemented medium. All CFSE
labeling and culturing were performed under dark conditions.
FACS analysis and cytokine assay. T-cells were stained with the
relevant antibody on ice for 30 min in PBS buffer containing 2% fetal
calf serum and 0.1% sodium azide. Cells were then washed twice,
ﬁxed with 1% paraformaldehyde, and analyzed with a FACSCalibur
four-color cytometer. Live cells were gated based on forward- and
side-scatter properties, and analysis was performed using FlowJo
software (Tree Star, Ashland, Oregon, United States). The following
antihuman antibodies were used for staining: CD3, CD4, CD45RO,
CD45RA, CD25, GITR, HLA-DR, CCR5, CCR4, CCR7, CXCR4,
CXCR3, and antimouse CD24, all obtained from PharMingen (San
Diego, California, United States). Cytokines (IL-2, IL-4, IL-5, and
IFNc) in the supernatants were assayed using a commercially
available cytometric bead array (CBA) (BD Biosciences Pharmingen)
(Cook et al. 2001) and analyzed using CBA 6-bead analysis software
(BD Biosciences Pharmingen).
Cloning of human FoxP3. RNA was isolated from activated human
T-cells using an RNeasy kit (Qiagen, Valencia, California, United
States). To synthesize cDNA 100 ng RNA was used (Superscript II
Reverse Transcriptase; Invitrogen, Carlsbad, California, United
States). FoxP3 was PCR ampliﬁed from T-cell cDNA with the following
primers: FoxP3 forward, 59-AGATATCCCAGCCATGCCCAACCC-
CAGGCCTGGCAAG-39; FoxP3 reverse, 59-TCAGGGGCCAGGTG-
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restriction site to facilitate cloning. The FoxP3 PCR product was
subcloned into a TOPO shuttle vector (pcDNA3.1/CT-GFP-TOPO;
Invitrogen). Following an EcoRV digest, FoxP3 was ligated into an
HDV-encoding mCD24 down stream of an internal ribosome entry
site (Sundrud et al. 2003). The FoxP3 coding sequence was conﬁrmed
by DNA sequencing.
Real-time PCR protocol. RNA was extracted, as described above,
from cells transduced with HDV or HDV.FoxP3 or sorted Treg, naı ¨ve,
and memory T-cells from HIV-positive and HIV-negative subjects.
RNA (100 ng) was used to synthesize cDNA (as described above).
Taqman Assays-on-Demand Gene Expression Primers (Applied
Biosystems, Foster City, California, United States) were used in real-
time PCR analyses: GAPDH primer mix assay ID Hs99999905_m1;
FoxP3 primer mix assay ID Hs00203958_m1.
Real-time PCR was performed using the ABI 7700 apparatus (PE
Applied Biosystems, Weiterstadt, Germany). The reaction mixtures
(20-ll total volume) contained 2 ll of serially diluted cDNA, 10 llo f
Taqman Universal PCR Master Mix (PE Applied Biosystems), and 1 ll
of either FoxP3 or GAPDH primer mix. The reactions were ampliﬁed
as follows: 50 8C for 2 min and 95 8C for 10 min, followed by 40 cycles
of 95 8C for 1 min and 65 8C for 1 min. Expression of FoxP3 was
normalized to GAPDH expression in each sample.
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